Armistice Capital, LLC Reports New 9.99% Stake in Intelligent Bio Solutions Inc. (INBS)

On May 15, 2026, Armistice Capital, LLC and its managing member, Steven Boyd, filed a Schedule 13G disclosing a new 9.99% stake in Intelligent Bio Solutions Inc. (INBS). The reporting persons acquired 163,571 shares of common stock, which are held directly by Armistice Capital Master Fund Ltd. Armistice Capital, LLC serves as the investment manager for the Master Fund and exercises shared voting and dispositive power over the securities. This filing represents a significant new position for the investment manager, crossing the 5% threshold as of the event date on March 31, 2026. The acquisition was made in the ordinary course of business and not for the purpose of influencing or changing control of the issuer. The filing includes a joint filing statement between Armistice Capital, LLC and Steven Boyd, confirming their shared beneficial ownership of the reported shares.